REAX vs. NVO
Compare and contrast key facts about Real Brokerage Inc (REAX) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REAX or NVO.
Correlation
The correlation between REAX and NVO is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REAX vs. NVO - Performance Comparison
Key characteristics
REAX:
0.24
NVO:
-1.07
REAX:
0.80
NVO:
-1.51
REAX:
1.09
NVO:
0.80
REAX:
0.35
NVO:
-0.75
REAX:
0.61
NVO:
-1.46
REAX:
22.05%
NVO:
30.77%
REAX:
56.21%
NVO:
42.23%
REAX:
-74.76%
NVO:
-71.29%
REAX:
-34.23%
NVO:
-51.94%
Fundamentals
REAX:
$897.21M
NVO:
$306.30B
REAX:
-$0.14
NVO:
$3.43
REAX:
0.71
NVO:
0.99
REAX:
27.91
NVO:
13.27
REAX:
$1.06B
NVO:
$225.05B
REAX:
$93.64M
NVO:
$190.45B
REAX:
-$8.78M
NVO:
$113.24B
Returns By Period
In the year-to-date period, REAX achieves a -4.78% return, which is significantly higher than NVO's -18.22% return.
REAX
-4.78%
4.04%
-17.82%
7.62%
N/A
N/A
NVO
-18.22%
10.68%
-37.16%
-42.62%
19.03%
11.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REAX vs. NVO — Risk-Adjusted Performance Rank
REAX
NVO
REAX vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Real Brokerage Inc (REAX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REAX vs. NVO - Dividend Comparison
REAX has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.33%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REAX Real Brokerage Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.33% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
REAX vs. NVO - Drawdown Comparison
The maximum REAX drawdown since its inception was -74.76%, roughly equal to the maximum NVO drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for REAX and NVO. For additional features, visit the drawdowns tool.
Volatility
REAX vs. NVO - Volatility Comparison
The current volatility for Real Brokerage Inc (REAX) is 13.09%, while Novo Nordisk A/S (NVO) has a volatility of 18.14%. This indicates that REAX experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REAX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Real Brokerage Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities